In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....